BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23121366)

  • 41. [The impact of antiviral therapy on virus-specific T-cell reactivity in patients with chronic hepatitis B].
    Feng X; Yan HP; Liao HY; Liu YM; Huang YL; Zhang GY; Lin F; Zhang X; Zhao Y; Zhang HP; Wang S; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):739-42. PubMed ID: 22781352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis.
    Soussan P; Tuveri R; Nalpas B; Garreau F; Zavala F; Masson A; Pol S; Brechot C; Kremsdorf D
    J Hepatol; 2003 Mar; 38(3):343-8. PubMed ID: 12586301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.
    Franzese O; Kennedy PT; Gehring AJ; Gotto J; Williams R; Maini MK; Bertoletti A
    J Virol; 2005 Mar; 79(6):3322-8. PubMed ID: 15731226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
    Nakazawa T; Shibuya A; Takeuchi A; Shibata Y; Hidaka H; Okuwaki Y; Takada J; Tanaka Y; Watanabe M; Minamino T; Sakurai K; Koizumi W
    J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):363-70. PubMed ID: 12506240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
    Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The relationship between clinical outcomes of hepatitis B virus infection and the host' s cellular immunity].
    Tian Y; Li TS
    Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):1014-7. PubMed ID: 18478920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
    Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
    Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Identification of circulating type II pre-dendritic cells (pDC2) and its clinical significance in chronic hepatitis B virus infection].
    Xing LH; Ma WP; Zhang XS; Shao XW; Ding XL; Peng JY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):247-9. PubMed ID: 17971935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients.
    Kountouras J; Boura P; Tsapas G
    Hepatogastroenterology; 1998; 45(24):2295-302. PubMed ID: 9951912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
    Boni C; Fisicaro P; Valdatta C; Amadei B; Di Vincenzo P; Giuberti T; Laccabue D; Zerbini A; Cavalli A; Missale G; Bertoletti A; Ferrari C
    J Virol; 2007 Apr; 81(8):4215-25. PubMed ID: 17287266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skewed T-cell receptor beta chain variable gene (TCRBV) usage among different clinical types of patients with chronic HBV infection.
    Yang J; Chen J; Mao H; Yi P; Yan D; He J; Li L
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):448-55. PubMed ID: 22469337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.
    Cao W; Qiu Z; Zhu T; Li Y; Han Y; Li T
    J Clin Virol; 2014 Sep; 61(1):40-6. PubMed ID: 25049205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy.
    de Niet A; Stelma F; Jansen L; Sinnige MJ; Remmerswaal EB; Takkenberg RB; Kootstra NA; Reesink HW; van Lier RA; van Leeuwen EM
    J Hepatol; 2016 Mar; 64(3):539-46. PubMed ID: 26505119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers.
    León B; Taylor L; Vargas M; Luftig RB; Albertazzi F; Herrero L; Visona K
    Virol J; 2005 Aug; 2():60. PubMed ID: 16080797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
    Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
    Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.